{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:13:19Z","timestamp":1773814399174,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.transproceed.2016.07.050","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T23:30:36Z","timestamp":1480980636000},"page":"2880-2883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody\u2013Low Titers"],"prefix":"10.1016","volume":"48","author":[{"given":"J.","family":"Kanter Berga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sancho Calabuig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gavela Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Puig Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Avila Bernabeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Crespo Albiach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Molina Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Beltr\u00e1n Catalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pallard\u00f3 Mateu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.07.050_bib1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2741\/2770","article-title":"The problem of transplanting the sensitized patient: whose problem is it?","volume":"13","author":"Jackson","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.transproceed.2016.07.050_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJMe1601379","article-title":"HLA-incompatible kidney transplantation: worth the risk?","volume":"10","author":"Rostaing","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.07.050_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humimm.2005.01.032","article-title":"Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin","volume":"66","author":"Zachary","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2016.07.050_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.07.050_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/TP.0b013e3181856f98","article-title":"Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy","volume":"86","author":"Reinsmoen","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/TP.0b013e3182962c84","article-title":"Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab","volume":"96","author":"Lovashevsky","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.transproceed.2016.07.050_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization","volume":"15","author":"Woddle","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib9","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.07.050_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2007.02072.x","article-title":"Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.07.050_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/TP.0b013e3181f6a07b","article-title":"Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes","volume":"90","author":"Singh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.transproceed.2012.09.102","article-title":"Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation","volume":"44","author":"Kanter","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.07.050_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.07.050_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/TP.0b013e318253f7b6","article-title":"Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients","volume":"94","author":"Alachkar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2215\/CJN.05930615","article-title":"Approach to the highly sensitized kidney transplant candidate","volume":"11","author":"Keith","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.07.050_bib19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneysto be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1034\/j.1600-6143.2002.20809.x","article-title":"Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulin","volume":"2","author":"Glotz","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib21","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG01 trial","volume":"15","author":"Jordan","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.07.050_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-6143.2005.01214.x","article-title":"Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients","volume":"6","author":"Jordan","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A\u00a0comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ndt\/gfl696","article-title":"Successful living donor kidney transplantation across HLA and ABO imcompatibilities","volume":"22","author":"Magee","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.transproceed.2011.11.040","article-title":"Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience","volume":"44","author":"Jin","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.07.050_bib26","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/TP.0b013e3182590d2e","article-title":"Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients","volume":"94","author":"Marfo","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.12659\/AOT.881860","article-title":"Limitations of rituximab\/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time?","volume":"16","author":"Kozlowski","year":"2011","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1600-6143.2008.02524.x","article-title":"Positive cross-match living donor kidney transplantation: longer-term outcomes","volume":"9","author":"Haririan","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.07.050_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/TP.0b013e3181837626","article-title":"Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels","volume":"86","author":"Issa","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.07.050_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516306674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516306674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:51:13Z","timestamp":1536198673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516306674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0041134516306674"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.07.050","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody\u2013Low Titers","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}